Factors influencing cotinine half-life during smoking abstinence in African American and Caucasian women

Nicotine and Tobacco Research

Volumn 4, Issue 4, 2002, Pages 423-431

  Ahijevych, Karen L ^a   Tyndale, Rachel F ^b   Dhatt, Ravinder K ^a   Weed, Harrison G ^a   Browning, Kristine K ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CIGARETTE SMOKE; COTININE; CYTOCHROME P450 2A6; DRUG METABOLITE; MENTHOL; NICOTINE;

ACCURACY; ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY COMPOSITION; CAUCASIAN; CIGARETTE SMOKING; CLINICAL PROTOCOL; CLINICAL RESEARCH; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG METABOLISM; ENVIRONMENTAL EXPOSURE; ETHNOLOGY; FEMALE; GENOTYPE; HUMAN; LEAN BODY WEIGHT; MORBIDITY; MORTALITY; NEGRO; PRIORITY JOURNAL; SMOKING CESSATION; SMOKING HABIT; VARIANCE;

AFRICAN AMERICANS; ARYL HYDROCARBON HYDROXYLASES; CHOICE BEHAVIOR; COTININE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPE; HALF-LIFE; HUMANS; MENTHOL; MIXED FUNCTION OXYGENASES; POLYMORPHISM, GENETIC; SMOKING; SMOKING CESSATION;

EID: 0036865684     PISSN: 14622203     EISSN: None     Source Type: Journal    
DOI: 10.1080/1462220021000018452     Document Type: Article

References (40)

1. Adir J., Wildfeuer W., Miller R. P. (1980). Effect of ethanol pretreatment on the pharmacokinetics of nicotine in rats. Journal of Pharmacology & Experimental Therapeutics 212, 274-279.
2. Ahijevych K., Parsley L. A. (1999). Smoke constituent exposure and stage of change in black and white women cigarette smokers. Addictive Behaviors 24, 115-120.
3. Ahijevych K., Wewers M. E. (1993). Factors associated with nicotine dependence among African American women cigarette smokers. Research in Nursing & Health 16, 283-292.
4. Ahijevych K., Wewers M. E. (1994). Patterns of cigarette consumption and cotinine levels among African American women smokers. American Journal of Respiratory & Critical Care Medicine 150, 1229-1233.
5. Ahijevych K., Gillespie J., Demirci M., Jagadeesh J. (1996). Menthol and nonmenthol cigarettes and smoke exposure in black and white women. Pharmacology Biochemistry & Behavior 53, 355-360.
6. 1. Proceedings of National Academy of Science of the USA 87, 4790-4793.
7. Benowitz N. L., Kuyt F., Jacob P. III, Jones R., Osman A. (1983). Cotinine disposition and effects. Clinical Pharmacology and Therapeutics 34, 604-611.
8. Benowitz N. L., Perez-Stable E. J., Fong I., Modin G., Herrera B., Jacob P. III. (1999). Ethnic differences in N-glucuronidation of nicotine and cotinine. Journal of Pharmacology and Experimental Therapeutics 291, 1196-1203.
9. Caraballo R., Giovino G., Pechacek T., Mower P., Richter P., Strauss W. J., Sharp D. J., Eriksen M. P., Pirkle J. L., Maurer K. R. (1998). Racial and ethnic differences in serum cotinine levels of cigarette smokers. The Journal of the American Medical Association 280, 135-139.
10. Clark P., Gautam S., Gerson L. W. (1996). Effect of menthol cigarettes on biochemical markers of smoke exposure among black and white smokers. Chest 110, 1194-1198.
11. Cohen J. (1988). Statistical power analysis for the behavioral sciences, (2nd ed). Hillsdale, NJ: Lawrence Erlbaum.
12. Cummings K, Giovino G, Mendicino A. (1987). Cigarette advertising and racial differences in cigarette brand preference. Public Health Reports 102, 698-701.
13. Crespi C. L., Penman B. W., Leakey J., Arlotto M., Stark A., Parkinson A., Turner T., Steimel D., Rudo K., Davies R. L., Langenbach R. (1990). Human cytochrome P450IIA3 cDna sequence, role of the enzyme in the metabolic activation of promutagens, comparison to nitrosamine activation by human cytochrome P450IIE1. Carcinogenesis 11, 1293-1300.
14. Eaton A., Israel R., O'Brien K., Hortobagyi T., McCammon M. (1993). Comparison of four methods to assess body composition in women. European Journal of Clinical Nutrition 47, 353-360.
15. Fagerström K. O., Heatherton T. F., Kozlowski L. T. (1990). Nicotine addiction and its assessment. Ear Nose & Throat Journal 69, 763-765.
16. Federal Trade Commission. (1991). Tar, nicotine and carbon monoxide of the smoke of 475 varieties of domestic cigarettes. Washington DC: Federal Trade Commission.
17. Fernandez-Salguero P., Hoffman S. M. G., Cholerton S., Mohrenweiser H., Raunio H., Pelkonen O., Huang J., Evans W. E., Idle J. R., Gonzales F. J. (1995). A genetic polymorphism in coumarin-hydroxylation: sequence of the human CPY2A genes and identification of variant CYP2A6 alleles. American Journal of Human Genetics 57, 651-660.
18. Gries J.-M., Benowitz N., Verotta D. (1996). Chronopharmacokinetics of nicotine. Clinical Pharmacological Therapeutics 60, 385-395.
19. Hariharan M., VanNoord T., Greden J. (1988). A high-performance liquid chromatography method for simultaneous determination of nicotine and cotinine in plasma. Clinical Chemistry 34, 724-729.
20. Heatherton T., Kozlowski L., Frecker R., Rickert W., Robinson J. (1989). Measuring the heaviness of smoking: using self-reported time to first cigarette of the day and number of cigarettes smoked per day. British Journal of Addiction 84, 791-800.
21. Heatherton T., Kozlowski L., Frecker R., Fagerström K. O. (1991). The Fagerström test for nicotine dependence: a revision of the Fagerström Tolerance Questionnaire. British Journal of Addiction 86, 1119-1127.
22. Jarvik M. E., Tashkin D. P., Caskey N. H., McCarthy W. J., Rosenblatt M. R. (1994). Mentholated cigarettes decrease puff volume of smoke and increase carbon monoxide absorption. Physiology & Behavior 56, 563-570.
23. Jarvis M. J., Russell M. A. H., Saloojee Y. (1987). Comparison of tests to distinguish smokers from non-smokers. American Journal of Public Health 77, 1435-1438.
24. Lee B. L., Jacob P. III, Jarvik M. E., Benowitz N. L. (1989). Food and nicotine metabolism. Pharmacology Biochemistry & Behavior 9, 621-625.
25. Lukaski H., Bolonchuk W., Hall C., Siders W. (1986). Validation of tetrapolar bioelectrical impedance method to assess human body composition. Journal of Applied Physiology 60, 1327-1332.
26. McCarthy W., Caskey N., Jarvik M. (1992). Ethnic differences in nicotine exposure. American Journal of Public Health 82, 1171-1172.
27. McCarthy W., Caskey N. H., Jarvik M. E., Gross T. M., Rosenblatt M. R., Carpenter C. (1995). Menthol vs. nonmenthol cigarettes: effects on smoking behavior. American Journal of Public Health 85, 67-72.
28. Messina E. S., Tyndale R. F., Sellers E. M. (1997). A major role for CYP2A6 in nicotine C-oxidation by human liver microsomes. Journal of Pharmacology & Experimental Therapeutics 282, 1608-1614.
29. Morgan D. J., Bray K. M. (1994). Lean body mass as a predictor of drug dosage. Implications for drug therapy. Clinical Pharmacokinetics 26, 292-307.
30. Nakajima M., Yamamoto T., Nunoya K., Yokoi T., Nagashima K., Inoue K., Funae Y., Shimada N., Kamataki T., Kuroiwa Y. (1996a). Characterization of CYP2A6 involved in 3′-hydroxylation of cotinine in human liver microsomes. Journal of Pharmacology & Experimental Therapeutics 277, 1010-1015.
31. Nakajima M., Yamamoto T., Nunoya K., Yokoi T., Nagashima K., Inoue K., Funae Y., Shimada N., Kamataki T., Kuroiwa Y. (1996b). Role of human cytochrome P4502A6 in C-oxidation of nicotine. Drug Metabolism & Disposition 11, 1212-1217.
32. Orani J., Anderson J., Sant' Ambrogio G., Sant' Ambrogio F. (1991). Upper airway cooling and l-menthol reduce ventilation in the guinea pig. Journal of Applied Physiology 70, 2080-2086.
33. Oscarson M., Gullsten H., Rautio A., Bernal M. L., Sinues B., Dahl M. L., Stengard J. H., Pelkonen O., Raunio H., Ingelman-Sundberg M. (1998). Genotyping of human cytochrome P450 2A6 (CYP2A6) a nicotine C-oxidase. FEBS Letter 438, 201-205.
34. Oscarson M., McLellan R., Gullsten H., Yue Q.-Y., Lang M. A., Bernal M. L., Sinues B., Hirvonen A., Raunio H., Pelkonen O., Ingelman-Sundberg M. (1999). Characterization and PCR-based detection of a CYP2A6 gene deletion found at high frequency in a Chinese population. FEBS Letter 448, 105-110.
35. Perez-Stable E. J., Herrera B., Jacob P. III, Benowitz N. L. (1998). Nicotine metabolism and intake in black and white smokers. The Journal of the American Medical Association 280, 152-156.
36. Rao Y., Hoffmann E., Zia M., Bodin L., Zeman M., Kalplan H., Sellers E. M., Tyndale R. F. (2000). Duplications and deletions in the CYP2A6 gene; Identification, genotyping and in vivo effects on smoking. Molecular Pharmacology 58, 747-755.
37. Seaton M. J., Vesell E. S. (1993). Variables affecting nicotine metabolism. Pharmacology Therapeutics 60, 461-500.
38. Sellers E. M. (1998). Pharmacogenetics and ethnoracial differences in smoking. The Journal of the American Medical Association 280, 179-180.
39. Tonnesen P. (1988). Dose and nicotine dependence as determinants of nicotine gum efficacy. Progress in Clinical & Biological Research 261, 129-144.
40. Wagenknecht L., Cutter G., Hale N., Sidney S., Manolio T., Hughes G. H., Jacobs D. R. (1990). Racial differences in serum cotinine, levels among smokers in the coronary artery risk development in (young) adults study. American Journal of Public Health 880, 1053-1056.